Balermpas P - Search Results

1

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG. Linge A, et al. Among authors: balermpas p. Radiother Oncol. 2016 Dec;121(3):364-373. doi: 10.1016/j.radonc.2016.11.008. Epub 2016 Nov 29. Radiother Oncol. 2016. PMID: 27913065

2

Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

Balermpas P, Hambek M, Seitz O, Rödel C, Weiss C. Balermpas P, et al. Strahlenther Onkol. 2009 Dec;185(12):775-81. doi: 10.1007/s00066-009-2092-7. Strahlenther Onkol. 2009. PMID: 20013086

3

Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results.

Balermpas P, Keller C, Hambek M, Wagenblast J, Seitz O, Rödel C, Weiss C. Balermpas P, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e377-83. doi: 10.1016/j.ijrobp.2011.12.088. Epub 2012 Mar 11. Int J Radiat Oncol Biol Phys. 2012. PMID: 22414284

4

Nuclear NF-κB expression correlates with outcome among patients with head and neck squamous cell carcinoma treated with primary chemoradiation therapy.

Balermpas P, Michel Y, Wagenblast J, Seitz O, Sipek F, Rödel F, Rödel C, Fokas E. Balermpas P, et al. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):785-90. doi: 10.1016/j.ijrobp.2013.04.001. Epub 2013 May 9. Int J Radiat Oncol Biol Phys. 2013. PMID: 23664323

5

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.

Balermpas P, Michel Y, Wagenblast J, Seitz O, Weiss C, Rödel F, Rödel C, Fokas E. Balermpas P, et al. Br J Cancer. 2014 Jan 21;110(2):501-9. doi: 10.1038/bjc.2013.640. Epub 2013 Oct 15. Br J Cancer. 2014. PMID: 24129245 Free PMC article.

6

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis.

Schulze B, Bergis D, Balermpas P, Trojan J, Woeste G, Bechstein WO, Rödel C, Weiss C. Schulze B, et al. Among authors: balermpas p. Oncol Lett. 2014 Feb;7(2):534-540. doi: 10.3892/ol.2013.1709. Epub 2013 Nov 27. Oncol Lett. 2014. PMID: 24396483 Free PMC article.

7

Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.

Balermpas P, Bauer C, Fraunholz I, Ottinger A, Wagenblast J, Stöver T, Seitz O, Fokas E, Rödel C, Weiss C. Balermpas P, et al. Strahlenther Onkol. 2014 Mar;190(3):256-62. doi: 10.1007/s00066-013-0509-9. Epub 2014 Jan 12. Strahlenther Onkol. 2014. PMID: 24413895

8

Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer.

Balermpas P, Rödel F, Weiss C, Rödel C, Fokas E. Balermpas P, et al. Oncoimmunology. 2014 Jan 1;3(1):e27403. doi: 10.4161/onci.27403. Oncoimmunology. 2014. PMID: 24711959 Free PMC article.

9

Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.

Rödel F, Wieland U, Fraunholz I, Kitz J, Rave-Fränk M, Wolff HA, Weiss C, Wirtz R, Balermpas P, Fokas E, Rödel C. Rödel F, et al. Among authors: balermpas p. Int J Cancer. 2015 Jan 15;136(2):278-88. doi: 10.1002/ijc.28979. Epub 2014 May 27. Int J Cancer. 2015. PMID: 24839133

10

Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences.

Balermpas P, Rödel F, Liberz R, Oppermann J, Wagenblast J, Ghanaati S, Harter PN, Mittelbronn M, Weiss C, Rödel C, Fokas E. Balermpas P, et al. Br J Cancer. 2014 Oct 14;111(8):1509-18. doi: 10.1038/bjc.2014.446. Epub 2014 Aug 5. Br J Cancer. 2014. PMID: 25093488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters